Clinical Trial | Health Technology Net

NetraMark Founder Coauthors New Publication on AI/ML Use in Clinical Trials, Alongside Authors From Leading Global Regulatory Organizations

TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0),…

7 months ago

TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0),…

7 months ago

TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0),…

7 months ago

Company expected to resume trading on the NYSE American on Tuesday, June 17, 2025OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE)…

7 months ago

Milestone paves the way for future reimbursement of the Nectero EAST® SystemTEMPE, Az., June 12, 2025 (GLOBE NEWSWIRE) -- Nectero…

7 months ago

Company expected to resume trading on the NYSE American on Tuesday, June 17, 2025OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE)…

7 months ago

Company expected to resume trading on the NYSE American on Tuesday, June 17, 2025OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE)…

7 months ago

Milestone paves the way for future reimbursement of the Nectero EAST® SystemTEMPE, Az., June 12, 2025 (GLOBE NEWSWIRE) -- Nectero…

7 months ago

Milestone paves the way for future reimbursement of the Nectero EAST® SystemTEMPE, Az., June 12, 2025 (GLOBE NEWSWIRE) -- Nectero…

7 months ago

Data are being presented at the 30th Annual Congress of the European Hematology Association 2025 (EHA2025)WOBURN, Mass., June 12, 2025…

7 months ago